Xenon Pharmaceuticals, Inc. (XENE)
54.12
-0.56
(-1.02%)
USD |
NASDAQ |
May 21, 16:00
54.15
+0.03
(+0.06%)
After-Hours: 19:59
Xenon Pharmaceuticals Research and Development Expense (TTM) : 325.78M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 34.23M |
| Alkermes Plc | 349.59M |
| Edesa Biotech, Inc. | 6.056M |
| ProMIS Neurosciences, Inc. | 34.89M |
| Tyra Biosciences, Inc. | 110.89M |